Fluoroauinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain

被引:62
作者
de la Campa, AG [1 ]
Balsalobre, L
Ardanuy, C
Fenoll, A
Pérez-Trallero, E
Liñares, J
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Genet Bacteriana, Madrid 28220, Spain
[2] Hosp Llobregat, Bellvitge Hosp, Barcelona, Spain
[3] Hosp Donostia, San Sebastian, Guipuzcoa, Spain
关键词
D O I
10.3201/eid1010.040382
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among 2,882 Streptococcus pneumoniae sent to the Spanish Reference Laboratory during 2002, 75 (2.6%) were ciprofloxacin-resistant. Resistance was associated with older patients (3.9% in adults and 7.2% in patients greater than or equal to65 years of age), with isolation from noninvasive sites (4.3% vs. 1.0%), and with penicillin and macrolide resistance. Among 14 low-level resistant (MIC 4-8 Ng/mL) strains, 1 had a fluoroquinolone efflux phenotype, and 13 showed single ParC changes. The 61 high-level ciprofloxacin-resistant (MIC greater than or equal to16 mug/mL) strains showed either two or three changes at ParC, ParE, and GyrA. Resistance was acquired either by point mutation (70 strains) or by recombination with viridans streptococci (4 strains) at the topoisomerase II genes. Although 36 pulsed-field gel electrophoresis patterns were observed, 5 international multiresistant clones (Spain(23F)-1, Spain(6B)-2, Spain(9V)-3, Spain(14)-5 and Sweden(15A)-25) accounted for 35 (46.7%) of the ciprofloxacin-resistant strains. Continuous surveillance is needed to prevent the dissemination of these clones.
引用
收藏
页码:1751 / 1759
页数:9
相关论文
共 39 条
[1]   Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain:: Clonal diversity and appearance of ciprofloxacin-resistant epidemic clones [J].
Alou, L ;
Ramirez, M ;
García-Rey, C ;
Prieto, J ;
de Lencastre, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2955-2957
[2]   Molecular characterization of the gene encoding the DNA gyrase a subunit of Streptococcus pneumoniae [J].
Balas, D ;
Fernández-Moreira, E ;
De la Campa, AG .
JOURNAL OF BACTERIOLOGY, 1998, 180 (11) :2854-2861
[3]   Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae [J].
Balsalobre, L ;
Ferrándiz, MJ ;
Liñares, J ;
Tubau, F ;
de la Carnpa, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2072-2081
[4]   Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae [J].
Bast, DJ ;
de Azavedo, JCS ;
Tam, TY ;
Kilburn, L ;
Duncan, C ;
Mandell, LA ;
Davidson, RJ ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2631-2634
[5]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800
[6]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[7]   Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): Novel major clones of serotypes 14, 19F and 15F [J].
Coffey, TJ ;
Berron, S ;
Daniels, M ;
GarciaLeoni, ME ;
Cercenado, E ;
Bouza, E ;
Fenoll, A ;
Spratt, BG .
MICROBIOLOGY-UK, 1996, 142 :2747-2757
[8]   Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States [J].
Corso, A ;
Severina, EP ;
Petruk, VF ;
Mauriz, YR ;
Tomasz, A .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04) :325-337
[9]   Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. [J].
Davidson, R ;
Cavalcanti, R ;
Brunton, JL ;
Bast, DJ ;
de Azavedo, JCS ;
Kibsey, P ;
Fleming, C ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) :747-750
[10]   In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada [J].
de Azavedo, JCS ;
Trpeski, L ;
Pong-Porter, S ;
Matsumura, S ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2299-2301